Navigation Links
Patient roused from coma by a magnetic field
Date:10/15/2008

JOSH VILLA was 26 and driving home after a drink with a friend on 28 August 2005 when his car mounted the kerb and flipped over. Villa was thrown through the windscreen, suffered massive head injuries and fell into a coma.

Almost a year later, there was little sign of improvement. "He would open his eyes, but he was not responsive to any external stimuli in his environment," says Theresa Pape of the US Department of Veterans Affairs in Chicago, who helped treat him.

Usually there is little more that can be done for people in this condition. Villa was to be sent home to Rockford, Illinois, where his mother, Laurie McAndrews, had volunteered to care for him.

But Pape had a different suggestion. She enrolled him in a six-week study in which an electromagnetic coil was held over the front of his head to stimulate the underlying brain tissue. Such transcranial magnetic stimulation (TMS) has been investigated as a way of treating migraine, stroke, Parkinson's disease and depression, with some promising results, but this is the first time it has been used as a potential therapy for someone in a coma-like state.

The rapidly changing magnetic fields that the coil creates can be used either to excite or inhibit brain cells - making it easier or harder for them to communicate with one another. In Villa's case, the coil was used to excite brain cells in the right prefrontal dorsolateral cortex. This area has strong connections to the brainstem, which sends out pulses to the rest of the brain that tell it to pay attention. "It's like an "OK, I'm awake" pulse," says Pape.

At first, there was little change in Villa's condition, but after around 15 sessions something happened. "You started talking to him and he would turn his head and look at you," says McAndrews. "That was huge."

Villa started obeying one-step commands, such as following the movement of a thumb and speaking single words. "They were very slurred but they were there," says Pape,
'/>"/>

Contact: Claire Bowles
claire.bowles@newscientist.com
44-207-611-1210
New Scientist
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... La Mirada, CA (PRWEB) , ... June 29, ... ... organizations, has announced that Dr. Gabriel Martin Del Campo is their newest FAA-certified ... Administration (FAA) physical examination is available for all fledging pilots seeking to obtain ...
(Date:6/29/2015)... ... June 29, 2015 , ... The Society for Immunotherapy ... (EMA) has granted accelerated approval of Bristol-Myers Squibb’s Opdivo® (nivolumab) for the treatment ... the approval of nivolumab for patients with metastatic melanoma in Europe represents a ...
(Date:6/29/2015)... ... ... Displays and Exhibits , a top online retailer of trade ... that include branding. Enter price code brand2015 for a ten percent discount on all ... promotional materials, all should integrate the company logo to communicate the brand. What is ...
(Date:6/29/2015)... ... 29, 2015 , ... Brittenford Systems, a provider of financial ... businesses across the United States, has announced that it has been named to ... year. , Based on company revenue and number of employees, Bob Scott’s Top ...
(Date:6/29/2015)... ... June 29, 2015 , ... Human Factors and Usability ... 16, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/humanfactors , ... engineering to the design of new products as well as to postmarket surveillance ...
Breaking Medicine News(10 mins):Health News:Healthpointe Now Offering FAA Physical Exams in San Bernardino County 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 3Health News:Stock Up on Logo Branding Tools Reduced this Month and Next Month from Displays and Exhibits 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 2Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 3
... focused new and improved interface. The most highlighting feature of this ... consumers to choose and buy their niche medicines any time. ... ... most reliable online pharmacy, launched a brand new customer focused, well ...
... for Two to International DestinationsSALT LAKE CITY, April 5 ... destination -- by winning it, with the launch of their ... Advanced." Schiff(R) will award seven grand prize winners a ... eight international destinations as well as 10,000 secondary prizes of ...
... 4 Inverness Medical Innovations, Inc. (NYSE: ... take charge of their health at home through the ... that it will attend the upcoming Goldman Sachs Leveraged ... 8, 2009 at the Goldman Sachs Conference Center located ...
... maker of lubricious HYDAK® hydrophilic coatings, and Agion Technologies, the ... co-marketing agreement to develop and promote a coatings product line ... ... Horsham, PA (PRWEB) April 4, 2009 -- ...
... Inc. (Nasdaq: BNVI ), a leader in the ... areas of women,s health and cancer, is scheduled to present ... City on April 9, 2009 at 3:45 p.m. MST.Mary Tagliaferri, ... The purpose of the presentation will be to update investors ...
... Departments Urge Public to Self-Report Suspected MeaslesHARRISBURG, Pa., April 3 ... Allegheny County Health Department and UPMC,s Children,s Hospital of Pittsburgh ... seen at Children,s Hospital. Exposures to measles may have occurred ... , ...
Cached Medicine News:Health News:Rxonlinetoday Launch Cyber Shop for FDA Approved Medicines 2Health News:Rxonlinetoday Launch Cyber Shop for FDA Approved Medicines 3Health News:Schiff Announces New 'Trip of a Lifetime' Sweepstakes 2Health News:Schiff Announces New 'Trip of a Lifetime' Sweepstakes 3Health News:Biocoat and Agion to Develop and Co-market Coatings for Medical Devices. 2Health News:Biocoat and Agion to Develop and Co-market Coatings for Medical Devices. 3Health News:Bionovo to Present at the Cambria Capital Investor Meeting 2Health News:Bionovo to Present at the Cambria Capital Investor Meeting 3Health News:Pennsylvania State Department of Health and Allegheny County Health Department Confirm Four Cases of Measles in Southwest Region 2Health News:Pennsylvania State Department of Health and Allegheny County Health Department Confirm Four Cases of Measles in Southwest Region 3
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Expected in November 2008, BOTHELL, Wash., Oct. 9 ... the completion of patient enrollment and dosing,for the third ... and,efficacy of its formulation of 12-hour extended-release (ER) ibuprofen ... top-line,results from this pivotal trial in November 2008. Ibuprofen ...
... Will Reduce Animal Use in Cosmetics and Chemicals ... Corp. today announced,that results of a recently completed ... EpiDerm in vitro human skin tissue,equivalent. The test ... to be accepted as a validated alternative to ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: